Biomerica Inc (BMRA) is not a strong buy for a beginner investor with a long-term strategy at this time. The stock is exhibiting bearish technical indicators, weak financial performance, and lacks positive catalysts or strong trading signals. Given the user's preference for long-term investment, it is advisable to hold off on investing in BMRA until there are clearer signs of recovery or growth.

Technical Analysis

The technical indicators are bearish. The MACD histogram is negative and expanding downward, the RSI is at 29.34 (neutral but close to oversold), and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 2.043, with resistance levels at 2.264 and 2.333.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Technical Summary

Sell

Buy

Positive Catalysts

NULL identified. No recent news, no significant hedge fund or insider activity, and no recent congress trading data.

Neutral/Negative Catalysts

The stock has experienced a -5.09% regular market change and a -4.65% pre-market change. Financial performance is weak, with a significant YoY revenue drop (-26.04%) and gross margin decline (-84.24%).

Financial Performance

In Q2 2026, revenue dropped by -26.04% YoY to $1,210,000. Net income improved slightly but remains negative at -$1,320,000 (up 38.95% YoY). EPS improved marginally to -0.45 (up 2.27% YoY). Gross margin dropped significantly to 4.21, down -84.24% YoY, indicating operational inefficiencies.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data available for analyst ratings or price target changes.

Analyst Rating

Wall Street analysts forecast BMRA stock price to rise

Buy

Hold

Sell

Current: 2.080

Low

Averages

High